| Income statement (USD) | FY 2025 ended Dec 31, 2025 | FY 2024 ended Dec 31, 2024 | FY 2023 ended Dec 31, 2023 | FY 2022 ended Dec 31, 2022 | FY 2021 ended Dec 31, 2021 | FY 2020 ended Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Revenue | 65.01B | 64.17B | 60.12B | 59.28B | 48.70B | 41.52B |
| Cost of revenue | 16.38B | 15.19B | 16.13B | 17.41B | 13.63B | 13.62B |
| Gross profit | 48.63B | 48.98B | 43.99B | 41.87B | 35.08B | 27.90B |
| Research and development | 15.79B | 17.94B | 30.53B | 13.55B | 12.24B | 13.40B |
| Selling, general and admin | 10.73B | 10.82B | 10.50B | 10.04B | 9.63B | 8.96B |
| Interest expense | 1.36B | 1.27B | 1.15B | 962.00M | 806.00M | 831.00M |
| Income before tax | 21.07B | 19.94B | 1.89B | 16.44B | 13.88B | 5.86B |
| Income tax | 2.80B | 2.80B | 1.51B | 1.92B | 1.52B | 1.34B |
| Net income | 18.25B | 17.12B | 365.00M | 14.52B | 12.35B | 7.07B |
| EPS | 7.30 | 6.76 | 0.14 | 5.73 | 5.16 | 2.79 |
| EPS (diluted) | 7.28 | 6.74 | 0.14 | 5.71 | 5.14 | 2.78 |
| Diluted shares | 2.51B | 2.54B | 2.55B | 2.54B | 2.54B | 2.54B |
| Dividends per share | 3.28 | 3.12 | 2.96 | 2.80 | 2.64 | 2.48 |
From Merck's 10-K and 10-Q filings with the SEC. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read income statement or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.